Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination
Abstract Background Antibodies with specificity for myelin oligodendrocyte glycoprotein (MOG) are implicated in multiple sclerosis and related diseases. The pathogenic importance of anti-MOG antibody in primary demyelinating pathology remains poorly characterized. Objective The objective of this stu...
Main Authors: | Carsten Tue Berg, Reza Khorooshi, Nasrin Asgari, Trevor Owens |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12974-017-0899-1 |
Similar Items
-
Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis
by: Mark D. Mannie, et al.
Published: (2012-08-01) -
Swimming Exercise Ameliorates Symptoms of MOG-Induced Experimental Autoimmune Encephalomyelitis by Inhibiting Inflammation and Demyelination in Rats
by: Ji-Youn Kim, et al.
Published: (2020-05-01) -
A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
by: Sonja Hochmeister, et al.
Published: (2020-02-01) -
Interferon-β Intensifies Interleukin-23-Driven Pathogenicity of T Helper Cells in Neuroinflammatory Disease
by: Agnieshka Agasing, et al.
Published: (2021-08-01) -
Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease
by: Shinji Yamamoto, et al.
Published: (2017-07-01)